JP2008523140A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523140A5
JP2008523140A5 JP2007546603A JP2007546603A JP2008523140A5 JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5 JP 2007546603 A JP2007546603 A JP 2007546603A JP 2007546603 A JP2007546603 A JP 2007546603A JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5
Authority
JP
Japan
Prior art keywords
separation matrix
matrix according
particles
binding protein
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007546603A
Other languages
English (en)
Japanese (ja)
Other versions
JP5787461B2 (ja
JP2008523140A (ja
Filing date
Publication date
Priority claimed from SE0403057A external-priority patent/SE0403057D0/sv
Application filed filed Critical
Priority claimed from PCT/SE2005/001900 external-priority patent/WO2006065208A1/en
Publication of JP2008523140A publication Critical patent/JP2008523140A/ja
Publication of JP2008523140A5 publication Critical patent/JP2008523140A5/ja
Application granted granted Critical
Publication of JP5787461B2 publication Critical patent/JP5787461B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007546603A 2004-12-14 2005-12-12 免疫グロブリンの精製方法 Expired - Lifetime JP5787461B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0403057-3 2004-12-14
SE0403057A SE0403057D0 (sv) 2004-12-14 2004-12-14 Purification of immunoglobulins
US63831604P 2004-12-22 2004-12-22
US60/638,316 2004-12-22
PCT/SE2005/001900 WO2006065208A1 (en) 2004-12-14 2005-12-12 Purification of immunoglobulins

Publications (3)

Publication Number Publication Date
JP2008523140A JP2008523140A (ja) 2008-07-03
JP2008523140A5 true JP2008523140A5 (cg-RX-API-DMAC10.html) 2008-12-11
JP5787461B2 JP5787461B2 (ja) 2015-09-30

Family

ID=36588164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546603A Expired - Lifetime JP5787461B2 (ja) 2004-12-14 2005-12-12 免疫グロブリンの精製方法

Country Status (5)

Country Link
EP (1) EP1830947A4 (cg-RX-API-DMAC10.html)
JP (1) JP5787461B2 (cg-RX-API-DMAC10.html)
AU (1) AU2005317279C1 (cg-RX-API-DMAC10.html)
CA (1) CA2586803C (cg-RX-API-DMAC10.html)
WO (1) WO2006065208A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12703738B2 (en) 2009-03-19 2026-08-11 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101374454B1 (ko) 2005-03-31 2014-03-17 추가이 세이야쿠 가부시키가이샤 회합제어에 의한 폴리펩티드 제조방법
JP5144499B2 (ja) 2006-03-31 2013-02-13 中外製薬株式会社 二重特異性抗体を精製するための抗体改変方法
EP4793360A2 (en) 2006-03-31 2026-08-19 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
CN101522278B (zh) 2006-09-29 2016-08-10 通用电气健康护理生物科学股份公司 用于抗体分离的包含来自金黄色葡萄球菌a蛋白的结构域c的层析配体
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
ES2687808T3 (es) 2007-09-26 2018-10-29 Chugai Seiyaku Kabushiki Kaisha Región constante de anticuerpo modificado
EP3127921A1 (en) 2007-09-26 2017-02-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substition in cdr
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
EP2543730B1 (en) 2010-03-04 2018-10-31 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
KR101855714B1 (ko) 2010-03-05 2018-05-10 베링거 인겔하임 인터내셔날 게엠베하 항체의 선택적 농축
WO2011114405A1 (en) * 2010-03-17 2011-09-22 Panasonic Corporation A method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate
KR20130055569A (ko) 2010-03-31 2013-05-28 제이에스알 가부시끼가이샤 친화성 크로마토그래피용 충전제
US9162161B2 (en) 2010-03-31 2015-10-20 Jsr Corporation Filler for affinity chromatography
CN105859889B (zh) 2010-11-17 2020-01-07 中外制药株式会社 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
TWI736437B (zh) 2010-11-30 2021-08-11 日商中外製藥股份有限公司 細胞傷害誘導治療劑
EP3040344B1 (en) 2013-08-30 2021-04-28 Kaneka Corporation Fab region-binding peptide
EP3042192A4 (en) * 2013-09-04 2017-04-26 Sten Ohlson Weak affinity chromatography
JP6230853B2 (ja) * 2013-09-06 2017-11-15 株式会社日立製作所 タンパク質の精製方法及び精製装置
CA2925256C (en) 2013-09-27 2023-08-15 Chugai Seiyaku Kabushiki Kaisha Method for producing polypeptide heteromultimer
EP3076170B1 (en) 2013-11-27 2023-09-06 JSR Corporation Solid-phase carrier and production method for filler for affinity chromatography
EP3094391B1 (en) 2014-01-17 2024-11-20 Repligen Corporation Sterilizing chromatography columns
EP3160982B1 (en) 2014-06-24 2020-10-28 Cytiva BioProcess R&D AB Chromatography method
WO2015199196A1 (ja) 2014-06-27 2015-12-30 Jsr株式会社 アフィニティークロマトグラフィー用担体
US20170334947A1 (en) * 2014-08-28 2017-11-23 Kaneka Corporation Affinity separation matrix for fab region-containing peptide
JPWO2016121701A1 (ja) 2015-01-26 2017-11-09 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
JP6663360B2 (ja) 2015-01-26 2020-03-11 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
SG11201803989WA (en) * 2015-12-28 2018-06-28 Chugai Pharmaceutical Co Ltd Method for promoting efficiency of purification of fc region-containing polypeptide
AU2017255077B2 (en) 2016-04-28 2024-05-16 Chugai Seiyaku Kabushiki Kaisha Antibody-containing preparation
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
JPWO2017195641A1 (ja) * 2016-05-11 2019-03-07 株式会社カネカ アフィニティ分離マトリックスの製造方法およびアフィニティ分離マトリックス
GB201703116D0 (en) * 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
JP7209298B2 (ja) 2017-03-31 2023-01-20 公立大学法人奈良県立医科大学 血液凝固第ｖｉｉｉ因子の機能を代替する多重特異性抗原結合分子を含有する、血液凝固第ｉｘ因子異常症の予防および／または治療に用いられる医薬組成物
KR20260090008A (ko) 2017-11-01 2026-06-16 추가이 세이야쿠 가부시키가이샤 생물 활성이 저하된 항체 배리언트 및 아이소폼

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5089605A (en) * 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5445732A (en) * 1992-06-19 1995-08-29 Sepracor Inc. Passivated porous polymer supports and methods for the preparation and use of same
WO1994022918A1 (en) * 1993-03-29 1994-10-13 Minnesota Mining And Manufacturing Company Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
SE9601368D0 (sv) * 1996-04-11 1996-04-11 Pharmacia Biotech Ab Process for the production of a porous cross-linked polysaccharide gel
EP1693402A3 (en) * 1997-01-07 2009-05-27 Kaneka Corporation Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification
SE9700383D0 (sv) * 1997-02-04 1997-02-04 Pharmacia Biotech Ab An adsorption/separation method and a medium for adsorption/separation
SE0004929D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for producing liquid chromatography matrices
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0300482D0 (sv) * 2003-02-21 2003-02-21 Amersham Biosciences Ab Inorganic beads with hierarchical pore structures
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
US20080312425A1 (en) * 2004-08-30 2008-12-18 Lonza Biologics Plc. Ion Exchange Chromatography and Purification of Antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12703738B2 (en) 2009-03-19 2026-08-11 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant

Similar Documents

Publication Publication Date Title
Ertürk et al. Cryogels-versatile tools in bioseparation
Saylan et al. Supermacroporous composite cryogels in biomedical applications
Purtov et al. Nanodiamonds as carriers for address delivery of biologically active substances
WO2006066598A3 (en) Antibody binding affinity ligands
Gooding et al. Hplc of biological macro-molecules, revised and expanded
Salimi et al. Protein A and protein A/G coupled magnetic SiO2 microspheres for affinity purification of immunoglobulin G
Vallhov et al. Dendritic cell‐derived exosomes carry the major cat allergen F el d 1 and induce an allergic immune response
BRPI0606375A2 (pt) método de produzir um sistema catalisador heterogêneo, sistema catalisador, e, método de catálise
JP2013507237A5 (cg-RX-API-DMAC10.html)
Caurie Hysteresis phenomenon in foods
JP2008517906A5 (cg-RX-API-DMAC10.html)
Chen et al. High performance of a unique mesoporous polystyrene-based adsorbent for blood purification
Weber et al. Development of specific adsorbents for human tumor necrosis factor-α: Influence of antibody immobilization on performance and biocompatibility
Mhemeed A general overview on the adsorption
EP0955332A4 (en) CELLULOLIC PARTICLES, SPHERICAL OBJECT CONTAINING NETWORKED POLYMER PARTICLES AND ABSORBENT FOR CLEANING BODY LIQUIDS
JP2010534336A5 (cg-RX-API-DMAC10.html)
Tvingsholm et al. TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Xu et al. Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis
Gustavsson et al. Superporous agarose as an affinity chromatography support
Soares et al. Molecular imprinting of β-cyclodextrin/cholesterol template into a silica polymer for cholesterol separation
Wei et al. Hierarchical macroporous agarose materials with polyethyleneimine-assisted multiple boronate affinity binding sites for the separation of neomycin
Weber et al. Development of affinity microparticles for extracorporeal blood purification based on crystalline bacterial cell surface proteins
SE0403057D0 (sv) Purification of immunoglobulins
JP2014512367A5 (cg-RX-API-DMAC10.html)
Thipe et al. Hybrid nanomaterials for detection, detoxification, and management mycotoxins